Allianz, Wins

Allianz Wins EU Nod for Floene Deal as Barclays Cools on the Sector and AI Exposure Mounts

Published on 11/22/2026 at 17:21 | Editorial boerse-global.de
Allianz posts record nine-month operating profit of EUR 14.1 billion, but Barclays stays Underweight while Jefferies lifts its target to EUR 470.
Allianz, Wins, Nod, Floene, Deal, Barclays, Cools, Sector, Exposure, Mounts Illustration mit AI erstellt.

Allianz opened the week with a regulatory green light and closed it with a share price under modest pressure, a fitting bookend for a stock that is delivering record operating profit while drawing sharply divided verdicts from the analyst community.

Brussels cleared the acquisition of Floene Energias on 13 November, with a consortium of Italgas and Allianz named as the buyers. The approval adds another strand to the insurer's long-running push to put capital to work outside its core underwriting book.

A record nine months, and a higher ceiling

The operational numbers behind that strategy remain robust. Operating profit for the third quarter of 2026 rose 6.2% to EUR 4.7 billion. Across the first nine months of the year, the figure climbed 7.8% to a record EUR 14.1 billion. Management also lifted the upper end of its full-year 2026 guidance for operating profit to roughly EUR 18.6 billion.

Two brokers, two targets, one shared caution

Barclays, for its part, turned negative on the European insurance sector as a whole on 17 November and kept Allianz at "Underweight." The bank pointed to fading earnings growth and what it regards as a rich valuation relative to peers. Even so, it raised its price target on the stock from EUR 351 to EUR 385. Barclays framed its sector call around share prices that have run well ahead of fundamentals it considers weaker.

Should investors sell immediately? Or is it worth buying Allianz?

Jefferies moved in the opposite direction on the target, lifting its own from EUR 440 to EUR 470 on Thursday while reaffirming a "Hold" rating. Analyst Philip Kett described the shares as a stabilising component of a portfolio, arguing that the very absence of obvious catalysts is itself a catalyst.

Investors leaned toward the cautious camp to close the trading week: the stock slipped 1.3% on Friday to settle at EUR 448.50.

An AI warning from the commercial arm

Running alongside the broker debate, Allianz Commercial sounded a warning on Thursday about growing and interlinked risks stemming from artificial intelligence. Critical AI incidents have risen by more than 150% over the past two years, according to the corporate insurer, which estimates that potential losses could reach triple-digit millions.

Allianz at a turning point? This analysis reveals what investors need to know now.

The technology cuts both ways inside the group. Reuters reported that roles at Allianz Partners could be eliminated over a period of 12 to 18 months, concentrated in call centres, citing a source familiar with the plans. The possible reduction was put at 1,500 to 1,800 positions, with the expanding use of artificial intelligence given as the reason.

Ad

Allianz Stock: New Analysis - 22 November

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

Disclaimer...
en | DE0008404005 | ALLIANZ | boerse | 70544647 |